期刊文献+

低密度脂蛋白受体基因AvaⅡ多态性与心肌梗死的关系研究 被引量:3

Relationship between AvaⅡ polymorphism of the LDL receptor gene and acute myocardial infarction
下载PDF
导出
摘要 目的 :探讨动脉粥样硬化致心肌梗死 ( AMI)与低密度脂蛋白受体基因( LDL- R) Ava 多态性的关系。方法 :用聚合酶链反应 ( PCR)技术检测 1 1 3例健康人和 81例 AMI患者的 LDL - R基因 Ava 多态性及血脂的含量。结果 :LDL- R基因 Ava 等位基因频率健康人 A+ 为 0 .2 30 ;AMI组 A+ 为 0 .32 7。 AMI组与对照组比较 LDL- R基因 Ava 多态性 A+ 型等位基因频率明显增高 ( P<0 .0 5 ) ;血清 TC、L DL- C、TG及 L P( a)水平亦明显增高 ( P<0 .0 1 )。结论 :Ava 多态性的 A+ 型等位基因可能与 AMI密切相关。 Objective:To investigate the relationship between AvaⅡ polymorphism of LDL receptor gene (LDL-R) and acute myocardial infarction of the Han nationality in Liaoning province. Methods:The polymerase chain reaction (PCR) technique was used to study the polymorphisms of LDL-R gene and allele frequencies in 81 patients with AMI and 113 age-matched Chinese healthy controls .The levels of the lipid and lipoproteins were also compared between the cases with AMI and the controls. Results :A + frequency of LDL-R gene in healthy controls and AMI group was 0.230 and 0.327 respectively. The frequency of the genotype A +A + (AvaⅡ) was greater in AMI group compared to the controls;in the AMI group A +A + genotype was associated with high concentrations of total cholesterol and LDL-C,TG, LP(a) in serum . Conclusion: The existence of A +A + can affect the concentration of serum lipid level and may be closely related to the occurrence of AMI.
出处 《陕西医学杂志》 CAS 北大核心 2004年第10期882-884,共3页 Shaanxi Medical Journal
关键词 AMI LDL 多态性 低密度脂蛋白受体 心肌梗死 健康人 R基因 等位基因频率 技术检测 水平 Coronary arteriosclerosis/complications Myocardial infarction/etiology Receptors,LDL/metabolism Polymorphism,restriction fragment length Polymerase chain reaction
  • 相关文献

参考文献6

二级参考文献13

  • 1吴松华,王延庆.Ⅱ型糖尿病患者低密度脂蛋白受体基因酶切多态性的观察[J].中华医学杂志,1993,73(1):10-13. 被引量:2
  • 2范乐明,蔡海江.低密度脂蛋白受体基因多态性及其与血清胆固醇水平...[J].中华医学杂志,1993,73(4):242-244. 被引量:4
  • 3Kuller LH.Future in lipid and lipoprotein research:form preventing clinical disease to preventing elevated risk factors.Atherosclerosis,1994,108(suppl):s143.
  • 4Sytkowski PA,Kannel WB,D’Agostino RB.Change in risk factors and the decline in mortality from cardiovascular disease.The Framingham Heart study.N Engl J Med,1990,322:1635-1641.
  • 5Ahn YI, Kamboh I, Chridtopher E, et al. Role of common polymorphism in the LDL receptor gene in affecting plasma cholesterol levels in the general population. Arterioscler Thromb,1994,14 : 663-670.
  • 6Khoury MJ, Flanders Wd. Nontraditional epidemiological approaches in the analysis of gene-environment interaction :casecontrol studies with no controls. Am J Epidemiol, 1996, 144:207-213.
  • 7Reavan GM, Hoffman BB. Hypertension as a disease of carbohydrate and lipoprotein metabolism. Am J Med, 1989, 87(suppl 6A) : 6A-2S-6A-6S.
  • 8Reilly SL, Ferrell RE, Kottke BA, et al. The gender-specific apolipoprotein of lipids and apolipoprotein in the population of Rochester, MN. I Pleioreophic effects on, eans and variances. Am J Hum Genet,1991,49:1155-1166.
  • 9Sigurdsson G Jr, Gudnasson V, Sigurdsson G, et al. Interaction between a polymorphism of the ApoA-I promoter region and smoking determines plasma levels of HDL and ApoA-I.Atheroscler Thromb, 1992,12:1017-1022.
  • 10Windler EET, Kovanen PT, Chao YS, et al. The estradiolstimulated lipoprotein receptor of rat liver: a binding site that mediates the uptake of rat lipoproteins containing apoprotein B and E. J Biol Chem, 1980,255:10464-10471.

共引文献18

同被引文献55

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部